Become a member

Cart (0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Renaissance London Heathrow Hotel

Oct 09, 2018 8:00 AM - Oct 10, 2018 5:30 PM

Bath Road, Hounslow, Middlesex, TW6 2AQ, United Kingdom

Value, Access, and Regulatory Strategy Conference

Paving the Way to the Future by Building Bridges

Back to Agenda

Session 1: EU Cooperation on HTA – Present and Future

Session Chair(s)

Claudine Sapède, PharmD

Claudine Sapède, PharmD

Director, Global HTA Policy

NOVARTIS INTERNATIONAL, Switzerland

Over the past 12 years much progress has been achieved on health technology assessment in Europe through the temporary funded EUnetHTA joint actions programme. Pilot projects on early scientific advice as well as relative effectiveness assessment have shown that stakeholders can collaborate successfully and the European Commission proposal published on January 31 aims at a regulation of HTA for a sustainable cooperation post 2020. The session will provide an overview of the main provisions of the proposal, the state of play, and timeline. Panelists will also be invited to reflect on what could be done to prepare for a permanent cooperation model.

Speaker(s)

Flora Giorgio, MPharm

Regulation of the European Parliament and of the Council on health technology assessment and amending Directive 2011/24/EU

Flora Giorgio, MPharm

European Commission, Belgium

Deputy Head of Unit Medical Devices, DG SANTE – Medical Products and Innovation

Chantal Guilhaume

EUnetHTA Perspective

Chantal Guilhaume

Haute Autorité De Santé (HAS), France

Scientific Project Manager

Marco Petschulies

The G-BA´s perspective

Marco Petschulies

G-BA, Germany

Scientific Assessor

François Houyez

Patients’ Perspective

François Houyez

European Organisation for Rare Diseases (EURORDIS), France

Treatment Information and Access Director, Health Policy Advisor

Ansgar Hebborn, PhD, MBA

Industry Perspective

Ansgar Hebborn, PhD, MBA

F. Hoffmann-La Roche AG, Switzerland

Head - Access Policy Affairs Europe

Have an account?